Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
PT Charlie Hospital Semarang Tbk Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | Rp374.00 |
52 Week High | Rp410.00 |
52 Week Low | Rp116.00 |
Beta | 0 |
11 Month Change | 2.19% |
3 Month Change | 53.28% |
1 Year Change | 214.29% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 185.50% |
Recent News & Updates
Recent updates
Shareholder Returns
RSCH | ID Healthcare | ID Market | |
---|---|---|---|
7D | -0.5% | -1.4% | -2.3% |
1Y | 214.3% | 24.8% | 14.9% |
Return vs Industry: RSCH exceeded the ID Healthcare industry which returned 24.8% over the past year.
Return vs Market: RSCH exceeded the ID Market which returned 14.9% over the past year.
Price Volatility
RSCH volatility | |
---|---|
RSCH Average Weekly Movement | 7.9% |
Healthcare Industry Average Movement | 5.1% |
Market Average Movement | 5.6% |
10% most volatile stocks in ID Market | 13.2% |
10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: RSCH has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: RSCH's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2019 | 216 | H. Junianto | charliehospital.co.id |
PT Charlie Hospital Semarang Tbk operates in the private hospital business in Indonesia. It offers medical services and support, inpatient, and medical check-up services, as well as operates wellness center. The company was founded in 2019 and is based in Kendal, Indonesia.
PT Charlie Hospital Semarang Tbk Fundamentals Summary
RSCH fundamental statistics | |
---|---|
Market cap | Rp991.10b |
Earnings (TTM) | -Rp524.98m |
Revenue (TTM) | Rp47.74b |
20.8x
P/S Ratio-1,888x
P/E RatioIs RSCH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RSCH income statement (TTM) | |
---|---|
Revenue | Rp47.74b |
Cost of Revenue | Rp33.16b |
Gross Profit | Rp14.57b |
Other Expenses | Rp15.10b |
Earnings | -Rp524.98m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.20 |
Gross Margin | 30.53% |
Net Profit Margin | -1.10% |
Debt/Equity Ratio | 26.6% |
How did RSCH perform over the long term?
See historical performance and comparison